Mitochondrial Augmentation Cell-therapy Platform
Minovia Therapeutics treats mitochondrial diseases through cell therapy using its Mitochondrial Augmentation Therapy (MAT) platform. The companys initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments. The company developed a cell therapy approach to treat a broad range of indications generated by a mitochondrial…